Insider Trading March 19, 2026

Pale Fire Capital-led group buys $18.3M of Phreesia stock, raises stake to 7.65M shares

Purchases span March 17-19 as Phreesia refinances debt and rolls out a provider engagement tool; analysts maintain mixed signals on valuation

By Nina Shah PHR
Pale Fire Capital-led group buys $18.3M of Phreesia stock, raises stake to 7.65M shares
PHR

A consortium including Pale Fire Capital entities and two individuals purchased 1,602,505 shares of Phreesia, Inc. (NASDAQ: PHR) between March 17 and March 19, 2026, for a total of $18.3 million. The transactions increased the group's holdings to 7,648,829 shares. The activity coincides with Phreesia's recent refinancing of its bridge loan, a product launch from Phreesia Network Solutions, and analyst updates that leave price targets clustered between $22 and $35.

Key Points

  • Pale Fire Capital-related entities and two individuals acquired 1,602,505 shares of PHR across March 17-19, 2026, for a total of $18.3 million, lifting their stake to 7,648,829 shares.
  • Phreesia refinanced its bridge loan with a new senior secured revolving credit facility of up to $275 million, borrowing about $92.2 million to repay prior debt.
  • Analyst coverage is mixed but generally constructive with price targets cited between $22 and $35 and recent ratings including a Buy and an Overweight; the company also launched ProviderConnect to engage providers.

A group of reporting persons identified as Pale Fire Capital SE, Pale Fire Capital SICAV a.s., Pale Fire Capital investicni spolecnost a.s., Dusan Senkypl, and Jan Barta disclosed purchases of Phreesia, Inc. (NASDAQ: PHR) common stock totaling $18.3 million.

The window for the acquisitions was March 17 through March 19, 2026. Across those three trading days the group acquired 1,602,505 shares at prices that ranged from $11.1531 to $11.6899 per share. The purchase cadence was: 303,300 shares on March 17, 519,196 shares on March 18, and 780,009 shares on March 19. After completing these transactions the groups aggregate ownership in Phreesia rose to 7,648,829 shares.

Market context is notable. PHR shares have declined by roughly 51 percent over the past six months and are trading near a 52-week low of $10.75. Separately, InvestingPro analysis cited in the disclosures indicates analysts price targets for PHR range between $22 and $35, suggesting a divergence between current market pricing and some analyst expectations.


Corporate and financing developments

In related corporate activity, Phreesia has refinanced an outstanding bridge loan by putting in place a new senior secured revolving credit facility with capacity of up to $275 million. Capital One, National Association is acting as agent for the lenders under the new facility. The company borrowed approximately $92.2 million under the new facility and used those proceeds to repay the prior debt, which was terminated without penalty.

On the product front, Phreesia Network Solutions introduced ProviderConnect, a digital application designed to help life sciences companies and healthcare marketers engage with healthcare providers by delivering treatment information before patient appointments.


Analyst moves and messaging

DA Davidson adjusted its price target for Phreesia to $30 from $35 while keeping a Buy rating. The firm said the change followed conversations with Phreesias chief financial officer about the companys longer-term growth potential and noted that growth could exceed current revenue guidance for fiscal 2027.

Wells Fargo initiated coverage of Phreesia with an Overweight rating and set a $30 price objective, emphasizing the companys role in managing patient intake, scheduling, and payments across a substantial portion of U.S. patient visits.


Ownership and beneficial interest

The shares are described as being indirectly owned by Pale Fire Capital SICAV a.s. The other named entities and individuals Pale Fire Capital SE, Pale Fire Capital investicni spolecnost a.s., Dusan Senkypl, and Jan Barta may be deemed to have beneficial ownership of the securities per the filing.


Summary takeaways

  • The group bought 1,602,505 Phreesia shares for $18.3 million between March 17 and March 19, 2026.
  • Post-transactions ownership increased to 7,648,829 shares.
  • Phreesia concurrently refinanced its bridge loan with a new $275 million senior secured revolving facility, drawing about $92.2 million to retire prior debt.
  • Phreesia Network Solutions launched ProviderConnect to deliver treatment information to providers ahead of appointments.
  • Analyst coverage shows mixed signals: DA Davidson lowered its price target to $30 but kept a Buy rating; Wells Fargo initiated with Overweight and a $30 target; InvestingPro-cited targets span $22 to $35.

Risks

  • Share-price volatility: PHR has fallen approximately 51 percent over the past six months and is trading near its 52-week low of $10.75, indicating downside pressure in the market for the stock.
  • Financing and liquidity risk: While Phreesia refinanced its bridge loan via a new $275 million revolver and drew $92.2 million to repay prior debt, the terms and future borrowing needs could affect the company's funding mix and liquidity.
  • Execution and adoption risk for new products: ProviderConnect is newly launched and its commercial uptake by life sciences companies and healthcare marketers is uncertain.

More from Insider Trading

Antero Resources Director Disposes $528,000 in Shares Near 52-Week High Mar 19, 2026 NerdWallet CBO Sells 72,288 Class A Shares for About $742,774; Retains 433,578 Stake Mar 19, 2026 NextNav CEO Sells $190,794 in Stock Under Pre-Arranged 10b5-1 Plan; Company Highlights Liquidity After Q4 Mar 19, 2026 BCP Investment Director Sells $416K in Stock Amid Mixed Quarterly Results Mar 19, 2026 Arvinas CMO Executes Automated Sale to Cover RSU Taxes; Company News Mixes Clinical Wins and Mixed Analyst Views Mar 19, 2026